Salicylic acid

Description

No relevant information is available to construct a Description section for the specified SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The drug should be administered as directed by a healthcare professional. Dosage may vary based on the patient's condition and response to treatment. It is essential to follow the prescribed dosage regimen strictly to ensure both efficacy and safety.

Administration of the drug must occur via the specified route as indicated in the prescribing information. The frequency of administration should adhere to the healthcare provider's instructions, which typically involves administration once or twice daily, depending on the specific treatment plan.

Contraindications

Use is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions.

Additionally, the product should not be used if discomfort persists, as this may indicate an underlying issue requiring medical evaluation. Ingestion of the product is contraindicated; immediate medical assistance or contact with a Poison Control Center is necessary if swallowed.

Contact with eyes should be avoided to prevent irritation or injury, and inhalation of vapors is contraindicated to mitigate respiratory risks.

Warnings and Precautions

For external use only, this product must be applied solely to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

General precautions should be observed to ensure safe usage. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided to minimize respiratory irritation. The bottle should be capped tightly after each use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained without delay if the product is swallowed. Prompt action is crucial in such situations to ensure safety and mitigate potential health risks.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Additionally, the product should be kept out of reach of children. In cases where the product is swallowed, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Ibealee Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for IBEALEE WART REMOVER. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not known. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients to avoid contact with the eyes; if the product does come into contact with the eyes, they should flush the eyes with water for at least 15 minutes. It is also important to caution patients against inhaling vapors from the product.

Patients should be reminded to securely cap the bottle after each use and to store the product in a cool, dry place, away from direct sunlight and heat, ideally at room temperature.

Healthcare providers should inform patients to discontinue use and seek medical advice if discomfort persists, or if they have diabetes or poor blood circulation. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ibealee Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)